Endologix Appoints Prof. Matthew Thompson as Chief Medical Officer

October 25, 2016—Endologix, Inc. announced the appointment of Matthew Thompson, MD, as Chief Medical Officer effective December 2016. He succeeds David Deaton, MD, who will continue to work with the company as a consultant.

According to the company, Prof. Thompson most recently served as Professor of Vascular Surgery at St. George’s, University of London and St. George’s Vascular Institute. He trained at Cambridge, St. Bartholomew’s Hospital, the University of Leicester and Adelaide. His awards include a Hunterian Professorship, the Moynihan travelling fellowship, and the gold medal for the intercollegiate examination. 

Prof. Thompson is the editor of the Oxford Textbook of Vascular Surgery and the Oxford Handbook of Vascular Surgery. He was Chair of the National Specialized Commissioning Clinical Reference Group for Vascular Services and is a founder of the British Society for Endovascular Therapy. Prof. Thompson is also a Council Member of the Vascular Society, Chairman of the Vascular Society Annual Scientific Meeting, and has been elected its President for 2018.

In the company’s announcement, Prof. Thompson commented, “I look forward to this new chapter in my career and am thrilled to be joining one of the most innovative companies in endovascular aortic therapy. Endologix’s passion and commitment to patient safety and outcomes makes the position a natural fit that allows me to continue serving patients with aortic disorders, but now on a global scale.”